Amphastar Pharmaceuticals' Shares Rise 3.7% Amid Positive Analyst Sentiment and Insider Buying

Shares of Amphastar Pharmaceuticals (AMPH) rose 3.7% after analysts' positive sentiment and technical indicators suggested potential upside. The stock traded above its 50-day and 200-day moving averages, and insider sentiment was reported as positive. Analysts' average price target was $32.00, and the stock had 14 moves greater than 5% over the last year.